Literature DB >> 2014996

Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media.

W T Stringfellow1, B Dassy, M Lieb, J M Fournier.   

Abstract

The production of type 5 capsular polysaccharide by Staphylococcus aureus in synthetic media was investigated. The influence of medium components on capsular polysaccharide synthesis appeared to relate to the presence or absence of the component rather than to concentration gradient. The production of type 5 capsular polysaccharide was linked to energy availability and energy source, but not to carbohydrate concentration or carbon/nitrogen ratio. Regulation of capsular polysaccharide production by S. aureus in response to medium changes would appear to differ from that typically displayed in other organisms that produce polysaccharides.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2014996      PMCID： PMC182763          DOI： 10.1128/aem.57.2.618-621.1991

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  21 in total

1.  Amino acid requirements of staphylococci isolated from human skin.

Authors:  M Emmett; W E Kloos
Journal:  Can J Microbiol       Date:  1975-05       Impact factor: 2.419

2.  The extracellualr polysaccharides of bacteria.

Authors:  J F WILKINSON
Journal:  Bacteriol Rev       Date:  1958-03

3.  Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus.

Authors:  D Taylor; K T Holland
Journal:  J Appl Bacteriol       Date:  1989-04

4.  Exopolysaccharide production by Pseudomonas NCIB11264 grown in continuous culture.

Authors:  A G Williams; J W Wimpenny
Journal:  J Gen Microbiol       Date:  1978-01

5.  Glucose repression of enterotoxins A, B and C and other extracellular proteins in staphlyococci in batch and continuous culture.

Authors:  A W Jarvis; R C Lawrence; G G Pritchard
Journal:  J Gen Microbiol       Date:  1975-01

6.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

7.  Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis.

Authors:  A Albus; J M Fournier; C Wolz; A Boutonnier; M Ranke; N Høiby; H Hochkeppel; G Döring
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus.

Authors:  A Boutonnier; F Nato; A Bouvet; L Lebrun; A Audurier; J C Mazie; J M Fournier
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Isolation of type 5 capsular polysaccharide from Staphylococcus aureus.

Authors:  J M Fournier; K Hannon; M Moreau; W W Karakawa; W F Vann
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  19 in total

1.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.

Authors:  D O Sordelli; F R Buzzola; M I Gomez; L Steele-Moore; D Berg; E Gentilini; M Catalano; A J Reitz; T Tollersrud; G Denamiel; P Jeric; J C Lee
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.

Authors:  Caroline M Kusuma; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.

Authors:  B Poutrel; P Rainard; P Sarradin
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

7.  Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Authors:  K B Kiser; J M Cantey-Kiser; J C Lee
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Survey of potential factors involved in the low frequency of CP5 and CP8 expression in Staphylococcus aureus isolates from mastitis of dairy cattle from Argentina, Chile, and Uruguay.

Authors:  Maria Belen Ambroggio; Melina Soledad Perrig; Cecilia Camussone; Nazarena Pujato; Alicia Bertón; Edgardo Gianneechini; Silvia Alvarez; Ivan Sergio Marcipar; Luis Fernando Calvinho; Maria Sol Barbagelata
Journal:  J Appl Genet       Date:  2018-05-03       Impact factor: 3.240

9.  Effects of nutrients on exopolysaccharide production and surface properties of Aeromonas salmonicida.

Authors:  R Bonet; M D Simon-Pujol; F Congregado
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

Review 10.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.